Hutchmed
Clinical trials sponsored by Hutchmed, explained in plain language.
-
Experimental lymphoma pill shows early promise but study halted
Disease control TerminatedThis early-stage study tested an oral drug called HMPL-523 in 69 adults with lymphoma that had returned or stopped responding to other treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink tumors. The study was stopped early, so re…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
Experimental IDH drug trial halted early
Disease control TerminatedThis early-stage study tested an experimental drug called HMPL-306 in people with advanced solid tumors that have a specific genetic change (IDH mutation). The main goals were to find a safe dose and check for side effects. The study was stopped early, so results are limited.
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Experimental IDH drug trial halted early – what we know
Disease control TerminatedThis early-stage study tested an experimental drug called HMPL-306 in 46 adults with advanced blood cancers that have a specific genetic change (IDH mutation). The main goals were to find a safe dose and check for side effects. The study was stopped early, so results are limited,…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 14, 2026 12:04 UTC